LAKE FOREST, Calif. – July 22, 2013 – Cryoport, Inc. (OTCBB: CYRX) today announced that it has reached agreement with Zoetis Inc. (formerly the animal health business unit of Pfizer Inc.) to expand the scope of the cold chain logistics services Cryoport is providing.
In December 2012, Cryoport signed an agreement with Pfizer Inc. relating to Zoetis Inc. (formerly the animal health business unit of Pfizer Inc.) pursuant to which we were engaged to manage frozen shipments of a key poultry vaccine. Under this arrangement, Cryoport is providing on-site logistics personnel and its logistics management platform, the CryoportalTM, to manage shipments from the Zoetis manufacturing site in the United States to domestic customers as well as selected international distribution centers. As part of its logistics management services, Cryoport analyzes shipping data and processes to further streamline Zoetis’ logistics, ensuring products arrive to their destinations in specified conditions, on-time and with the optimum uses of resources. Initially, Cryoport managed Pfizer’s total fleet of dewar flask shippers used for this purpose, including liquid nitrogen shippers.